ABOUT THE TOPIC
This collaboration is about what benefits people with dementia could gain from legal cannabis treatments. The University of Saskatchewan (U of S) and Sundial Growers Inc. agreed on a three-year memorandum of understanding (MUO). The main goal of this partnership is to explore opportunities for clinical testing. In order to see what advantage occur from cannabis-related health solutions.
ABOUT THE COLLABORATION
The area that was chosen for those clinical trials is dementia. The main reasoning for this is the huge international concerns about the impact of dementia, now more and more countries have to deal with an ageing population, including the increase of patient with dementia.
“The study aims to examine to what degree patients with dementia can tolerate the side effects of the cannabis drug.”
ABOUT THE BENEFITS
This partnership between the business will create opportunities for specific trainees and faculty for projects that will advance the understanding of the medicinal applications of cannabis and could secure other partnerships funding for trainee sponsorships.
ABOUT THE OUTCOME
Secondary outcomes of the study include the increase in more knowledge about the impact of cannabis. This includes areas such as patient anxiety, aggression, sleep, pain, cognitive stabilization, and nutrition.
ABOUT THE RESEARCH
This study includes randomized and placebo-controlled dose-escalation. This research will take place at two different extended care facilities in Saskatoon. The study aims to examine to what degree patients with dementia can tolerate the side effects of cannabis, the dosage, and any adverse effects of dose escalation.
ABOUT THE PARTNERS
The partners that are involved with this three-year partnership, include Professor Karen Chad, The vice-president of U of S. Jane Alcon responsible for the co-lead of the biomedical branch in the College of Pharmacy and Nutrition and the president of the Sundial: Geoff Thompson.
The article was published on October 9th 2018.
Source can be found here
Photo by Alexandre Chambon on Unsplash